Evidence map›Paper›PMID 39387051›Full record

ReviewFrontiers in endocrinology2024

Neuroprotective effects of magnesium: implications for neuroinflammation and cognitive decline.

Veer Patel, Nuraly S Akimbekov, William B Grant, Carolyn Dean, Xiaoqian Fang, Mohammed S Razzaque

Abstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Review
  2. Protective effect of magnesium on indomethacin-induced gastric ulcer in mice.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Mapping the future of medicine through digital twins.Frontiers in molecular medicine · 2026
    Review
  12. Article
  13. Article
  14. Maternal and Fetal Magnesium Balance: Impacts and Implications.Advances in experimental medicine and biology · 2026
    Review
  15. Review
  16. Unraveling the Effects ofInternational journal of molecular sciences · 2025
    Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Veer PatelDepartment of Pathology, Lake Erie College of Osteopathic Medicine, Erie, PA, United States.
Nuraly S AkimbekovScientific-Practical Center, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan.
William B GrantSunlight, Nutrition, and Health Research Center, San Francisco, CA, United States.
Carolyn DeanNew Capstone, Inc., Mooresville, NC, United States.
Xiaoqian FangDepartment of Neuroscience, School of Medicine, University of Texas Rio Grande Valley (UTRGV), Edinburg, TX, United States.
Mohammed S RazzaqueDepartment of Pathology, Lake Erie College of Osteopathic Medicine, Erie, PA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurodegenerative diseases, which are characterized by progressive neuronal loss and cognitive decline, are a significant concern for the aging population. Neuroinflammation, a shared characteristic of these diseases, is implicated in their pathogenesis. This article briefly summarizes the role of magnesium, an essential mineral involved in numerous enzymatic reactions and critical for neuronal bioactivity, in the context of neuroinflammation and cognitive decline. The potential neuroprotective effects of magnesium, including the mechanisms of neuroprotection by magnesium through maintaining neuronal ion homeostasis, reducing inflammation, and preventing excitotoxicity, are also described. Additionally, we discuss the impact of inadequate magnesium on neuroinflammation and its potential as a therapeutic agent for attenuating cognitive decline to improve neurodegenerative conditions.

Indexed as

Cognitive DysfunctionMagnesiumNeuroinflammatory DiseasesNeuroprotective AgentsAnimalsHumansInflammationNeurodegenerative DiseasesMagnesiumNeuroprotective Agentscognitive declinemagnesiumneurodegenerative diseaseneuroinflammationneuroprotection

Identifiers

PMID39387051
PMCPMC11461281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.